Gillian Barratt obtained a first degree in biochemistry from the University of Cambridge, Cambridge, UK, in 1976, and then completed a Ph.D. degree at the Department of Biochemistry, St. Bartholomew’s Hospital Medical College, London, UK, on “The effect of various antitumor treatments on lysosomal membrane fragility and enzyme activity in a mouse mammary tumor model.” This was followed by a Postdoctoral Fellowship at the Laboratory of Professor Brenda Ryman at the University of London, London, UK, working on liposomes as aids to tumor imaging, before moving to Paris in 1983. At this time, her interests were centered on the use of liposomes and nanoparticles to carry immunomodulating compounds. She has been a Staff Researcher in CNRS since 1990 and Research Director since 1998, attached to the Institut Galien Paris‐Sud at the School of Pharmacy of the Université Paris‐Sud 11, Orsay, France, headed by Professor Elias Fattal. Her research interests are still focused on nanosized colloidal systems as drug delivery vehicles. These systems are designed to deliver an active molecule to its site of action more efficiently and avoid toxicity and are particularly applicable to anticancer and anti-infectious drugs. She has published over 90 articles in peer-reviewed journals and written 15 book chapters. She is an active Member of the Board of the French Society for Nanomedicine (formerly GTRV), an association which promotes scientific exchanges in the field of drug delivery, and has helped to organize many conferences and summer schools. She has supervised many Ph.D. and M.S. degree students and participated in international teaching programs such as the Erasmus Program.
Biography Updated on 21 August 2014